ArticleCureus2026
Automatic Frequent Measurements of Plasma Sodium, Potassium, Total Carbon Dioxide, Urea Nitrogen, and Other Values During Hemodialysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Customizing acute and chronic hemodialysis treatments by tailoring the prescription can occur by knowing the patient's electrolyte and acid-base status at any given moment. Point-of-care (POC) testing using whole blood samples can provide laboratory results of sodium, potassium, chloride, bicarbonate, glucose, calcium, phosphorus, blood urea nitrogen, creatinine, pH, partial pressure of carbon dioxide, oxygen, and lactate. The impact of dialysis on these values will impact patient outcomes and quality of life. Besides knowing the laboratory results, one can calculate the anion gap and osmolar gap to treat patients with disorders such as diabetic ketoacidosis and alcohol poisoning, respectively. We describe a new technology for obtaining blood samples from the hemodialysis arterial line and using a POC device installed in the dialysis machine to perform electrolyte and blood gas measurements, and inform the clinician promptly of possible prescription adjustments to meet the needs of the patient requiring acute or chronic hemodialysis. Besides the obvious benefits, we highlight some pitfalls associated with using whole blood versus serum samples, and arterial versus venous blood samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.